title: Similar favorable outcome of pegfilgrastim overdose in patients with different age and underlying disease.
authors.forename: Carlo
authors.initials: C
authors.lastname: Dufour
authors.forename: Barbara
authors.initials: B
authors.lastname: Cappelli
authors.forename: Michaela
authors.initials: M
authors.lastname: Calvillo
authors.forename: Francesca
authors.initials: F
authors.lastname: Fioredda
authors.forename: Rossella
authors.initials: R
authors.lastname: Tonelli
authors.forename: Roberto
authors.initials: R
authors.lastname: Crocchiolo
mesh_terms: D000367:Age Factors; D000368:Aged; D002675:Child, Preschool; D062787:Drug Overdose; D000069585:Filgrastim; D016179:Granulocyte Colony-Stimulating Factor / Q000009:adverse effects*; D006801:Humans; D008297:Male; D009503:Neutropenia / Q000188:drug therapy* / Q000473:pathology; D011092:Polyethylene Glycols; D011994:Recombinant Proteins; D012751:Sezary Syndrome / Q000188:drug therapy* / Q000473:pathology; D016896:Treatment Outcome
chemical_list: D011994:Recombinant Proteins; D016179:Granulocyte Colony-Stimulating Factor; C455861:pegfilgrastim; D011092:Polyethylene Glycols; D000069585:Filgrastim